Зөвхөн бүртгэлтэй хэрэглэгчид л нийтлэл орчуулах боломжтой
Нэвтрэх / Бүртгүүлэх
TECHNICAL FIELD
The present invention relates to a novel agent or composition for use as a muscle-strengthening drug, an anti-inflammatory drug, an antiasthmatic, an antidiarrheal, an antidepressant, or a drug for the treatment of secondary diseases following cerebral infarction (human stroke
Зөвхөн бүртгэлтэй хэрэглэгчид л нийтлэл орчуулах боломжтой
Нэвтрэх / Бүртгүүлэх
BACKGROUND OF THE INVENTION
The farnesoid X receptor (FXR), the peroxisome proliferator-activated receptor .alpha. (PPAR.alpha.), and the liver X receptor .alpha. (LXR.alpha.) are members of a superfamily of approximately 150 proteins that bind to cis-acting elements in the promoters of their target
Зөвхөн бүртгэлтэй хэрэглэгчид л нийтлэл орчуулах боломжтой
Нэвтрэх / Бүртгүүлэх
BACKGROUND OF THE INVENTION
The farnesoid X receptor (FXR), the peroxisome proliferator-activated receptor .alpha. (PPAR.alpha.), and the liver X receptor .alpha. (LXR.alpha.) are members of a superfamily of approximately 150 proteins that bind to cis-acting elements in the promoters of their target